CDRH PMA Review Performance Improves In FY 2000 Wrap-Up
This article was originally published in The Gray Sheet
Executive Summary
FDA's average review time for PMAs in fiscal year 2000 dropped to 8.1 months, a decrease of approximately one month compared to the previous year.